NCT04676763View on ClinicalTrials.gov

Substance P Challenge in Healthy Participants

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Skin Diseases
Interventions
DRUG

Substance P

Participants will receive Substance P

DRUG

Normal Saline

Participants will receive normal saline as Negative control

DRUG

Histamine

Participants will receive histamine as Positive control

Trial Locations (1)

2333 CL

GSK Investigational Site, Leiden

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04676763 - Substance P Challenge in Healthy Participants | Biotech Hunter | Biotech Hunter